Susan B. Kesmodel

home / authors / susan-b-kesmodel

Articles

43 Impact of Lymphatic Microsurgical Preventing Healing Approach (LYMPHA) on Postoperative Complication Rates in Mastectomy With Immediate Prosthetic-Based Breast Reconstruction

43 Impact of Lymphatic Microsurgical Preventing Healing Approach (LYMPHA) on Postoperative Complication Rates in Mastectomy With Immediate Prosthetic-Based Breast Reconstruction

Anshumi Desai;Emily Finklestein;Meaghan Clark;Rohan Mangal;Iago De Castro Silva;Susan B. Kesmodel;Kristin E. Rojas;Devinder Singh;Kyle Xu;Juan Catinchi-Mella
May 29th 2024
44 Variant of Uncertain Significance (VUS) Genetic Testing Results and Mastectomy Choice in Lumpectomy-Eligible Patients

44 Variant of Uncertain Significance (VUS) Genetic Testing Results and Mastectomy Choice in Lumpectomy-Eligible Patients

Osvaldo Nunez;Vasanth Govind;Tizita Wolde;Rainya Heath;Talia R. Donenberg;Rachel Silva-Smith;Marie B. Jeanjean;Jessica Moore;Jessica Crystal;Susan B. Kesmodel;Kristin E. Rojas
May 28th 2024

Latest Updated Articles

NSABP B-42 trial results show that the assay was predictive of extended letrozole therapy response, identifying a patient subset with improved outcomes.
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Data from the CheckMate-67T trial support the biologics license application for subcutaneous nivolumab in multiple solid tumors.
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes
Published: August 26th 2011 | Updated: September 8th 2024
Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes
Neonate With a Soft, Yellowish-Colored Plaque on the Temple
Published: July 16th 2011 | Updated: September 8th 2024
Neonate With a Soft, Yellowish-Colored Plaque on the Temple
Regardless of T790M status, lazertinib hindered the progression of intracranial metastases after unsuccessful EGFR TKI treatment in patients with EGFR-mutated NSCLC.
Published: August 29th 2024 | Updated: September 8th 2024
Lazertinib Shows Encouraging Intracranial ORR in EGFR NSCLC with CNS Metastases